ask="0.250"
ask_size="20000"
average_daily_volume="5491600"
bid="0.206"
bid_size="3300"
book_value="0.104"
change="+0.018"
change_from_200_day_moving_average="-0.079"
change_from_50_day_moving_average="0.026"
change_from_52_week_high="-0.436"
change_From_52_week_low="0.059"
change_in_percent="+9.184%"
close="0.214"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.678"
ebitda="-16.86M"
eps_estimate_current_year="-0.520"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="0.510"
ex_dividend_date="N/A"
float_shares="124109000"
high="0.221"
high_52_weeks="0.650"
last_trade_date="1/13/2017"
last_trade_price="0.214"
last_trade_size="488"
last_trade_time="4:00pm"
low="0.192"
low_52_weeks="0.155"
market_capitalization="28.10M"
moving_average_200_day="0.293"
moving_average_50_day="0.188"
name="Immune Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="3.000"
open="0.195"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-27.004%"
percent_change_from_50_day_moving_average="+13.720%"
percent_change_from_52_week_high="-67.077%"
percent_change_from_52_week_low="+37.975%"
previous_close="0.196"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="0.420"
price_per_book="1.885"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="131291000"
short_ratio="0.790"
stock_exchange="NCM"
symbol="IMNP"
volume="7742399"
weeks_range_52="0.155 - 0.650"
